Increasing access to investigational drugs.
作者信息
Christian Michaele
机构信息
Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program, National Cancer Institute.
出版信息
Clin Adv Hematol Oncol. 2004 Feb;2(2):90-1.
PMID:16163167
Abstract
摘要
相似文献
1
Increasing access to investigational drugs.增加获取研究性药物的机会。
Clin Adv Hematol Oncol. 2004 Feb;2(2):90-1.
2
Can single-patient investigational new drug studies hurry slow trains to the fast track?单患者研究性新药研究能否让慢车加速驶入快车道？
Drug Discov Today. 2006 Mar;11(5-6):185-6. doi: 10.1016/S1359-6446(05)03707-4.
3
The role of the National Cancer Institute in drug development.美国国立癌症研究所在药物研发中的作用。
Clin Adv Hematol Oncol. 2005 Apr;3(4):257-8.
4
New office and new leader aim to streamline FDA cancer drug review process.新办公室和新领导旨在简化美国食品药品监督管理局（FDA）的癌症药物审评流程。
J Natl Cancer Inst. 2005 May 18;97(10):708-9. doi: 10.1093/jnci/97.10.708.
5
Slow start to phase 0 as researchers debate value.由于研究人员对价值存在争议，0期研究起步缓慢。
J Natl Cancer Inst. 2006 Jun 21;98(12):804-6. doi: 10.1093/jnci/djj249.
6
Clinical trials referral resource. Current clinical trials of bortezomib.临床试验转诊资源。硼替佐米的当前临床试验。
Oncology (Williston Park). 2003 May;17(5):677-80, 683-6, 691-2.
7
Japan works to shorten "drug lag," boost trials of new drugs.日本致力于缩短“药品滞后”现象，推动新药试验。
J Natl Cancer Inst. 2010 Feb 3;102(3):148-51. doi: 10.1093/jnci/djq017. Epub 2010 Jan 27.
8
Diabetes Prevention Program meets recruitment goals.糖尿病预防计划达到招募目标。
Diabetes Technol Ther. 1999 Fall;1(3):350-1.
9
Investigational new drugs in cancer chemotherapy.
Minn Med. 1979 Jul;62(7):536-8.
10
Investigational trials of anticancer drugs: establishing safeguards for experimentation.抗癌药物的试验性试验：建立实验保障措施。
Public Health Rep. 1984 Jul-Aug;99(4):355-60.
Zotero 插件